US Stock MarketDetailed Quotes

BEAM Beam Therapeutics

Watchlist
  • 24.910
  • +0.450+1.84%
Close Aug 8 16:00 ET
  • 24.910
  • 0.0000.00%
Post 20:01 ET
2.05BMarket Cap-15376P/E (TTM)

Beam Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beam Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

--

Revenue(YoY)

11.77M

-41.48%
EPS(YoY)

-1.11

-2.78%
Analyst Rating

Buy

Aug 7, 2024

Beam Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 14.243M--
--2024/Q3-- / 13.632M--
--2024/Q211.772M / 13.047M--
--2024/Q17.410M / 14.664M--
--2023/Q4316.192M / 33.673M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 14.243M--
--2024/Q3-- / 13.632M--
--2024/Q211.772M / 13.047M--
--2024/Q17.410M / 14.664M--
--2023/Q4316.192M / 33.673M--

Unlock Free Earnings Estimates

Beam Therapeutics Earnings Reports

  • Beam Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 08:58 ET

  • Beam Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 7 07:24 ET

  • Beam Therapeutics | 10-K: FY2023 Annual Report

    Feb 27 07:25 ET

  • Beam Therapeutics: Q3 2023 Earnings Report

    Nov 8, 2023 07:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 7, 2024

    Buy

    • Buy

      62.50%

    • Hold

      37.50%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept ARK Portfolio
    ARK Portfolio
    Intraday+4.62%
    Gene Editing
    Gene Editing
    Intraday+0.91%